藥明康德(02359.HK)參股公司JW (Cayman) Therapeutics Co.,Ltd.在港交所掛牌上市
格隆匯 11 月 3日丨藥明康德(02359.HK)公告,無錫藥明康德新藥開發股份有限公司(以下簡稱“公司”)參股公司JW(Cayman)TherapeuticsCo.,Ltd.(以下簡稱“JWCayman”)於2020年11月3日在香港聯合交易所有限公司(以下簡稱“香港聯交所”)主板掛牌上市,股份代號:02126.HK。
JWCayman本次資本化發行及全球發售完成前,公司通過全資子企業WuXiAppTec(HongKong)HoldingLimited(以下簡稱“藥明香港控股”)持有JWCayman38,232,570股股份(該股數為本次資本化發行及全球發售完成前經JWCayman拆股及配股調整後的持股數),佔JWCayman總股本的13.73%,JWCayman本次全球發售完成後(假設超額配股權未獲行使,且員工股份激勵計劃未立即行權),本公司通過全資子企業藥明香港控股持有JWCayman總股本的10.16%。
若後續JWCayman行使全部或部分超額配股權,公司通過全資子企業藥明香港控股持有JWCayman的股比將進一步稀釋。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.